End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates

Hepatology

Volumn 55, Issue 1, 2012, Pages 192-198

  Sharma, Pratima ^a   Schaubel, Douglas E ^b   Gong, Qi ^b   Guidinger, Mary ^c   Merion, Robert M ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; PARACETAMOL;

ADULT; AGE; ARTICLE; DIABETES MELLITUS; DIALYSIS; END STAGE LIVER DISEASE; FEMALE; GRAFT RECIPIENT; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SCORING SYSTEM; SEX DIFFERENCE; SURGICAL PATIENT; SURVIVAL RATE; SURVIVAL TIME; WAIT LIST MORTALITY;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; WAITING LISTS; YOUNG ADULT;

EID: 84155188928     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24632     Document Type: Article

References (16)

1. United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN). 3.6 Organ Distribution: Allocation of Livers. Policies. Volume 2011, 2002. Accessed September 2011.
2. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464-470.
3. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
4. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 2001; 7: 567-580.
5. Kremers WK, van IM, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. HEPATOLOGY 2004; 39: 764-769.
6. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data, 2nd ed. New York: Wiley; 2002.
7. Schaubel DE, Guidinger MK, Biggins SW, Kalbfleisch JD, Pomfret EA, Sharma P, et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009; 9: 970-981.
8. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
9. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313.
10. Berg CL, Steffick DE, Edwards EB, Heimbach JK, Magee JC, Washburn WK, et al. Liver and intestine transplantation in the United States 1998-2007. Am J Transplant 2009; 9: 907-931.
11. Scientific Registry of Transplant Recipients. 2010 Annual Data Report of the U.S. Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2009.
12. Hunsicker LG Collins TW, Voigt MD; for the UNOS FNMS>Region 8 Liver Transplant Centers. Outcomes of region-wide sharing to candidates with MELD >29 in Region 8 [Abstract]. Am J Transplant 2010; 10: 58.
13. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 2007; 13: 822-828.
14. Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria. Liver Transpl 2007; 13: 814-821.
15. Taylor RM, Davern T, Munoz S, Han SH, McGuire B, Larson AM, et al. Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. HEPATOLOGY 2006; 44: 1589-1597.
16. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. HEPATOLOGY 2007; 45: 789-796.